110 related articles for article (PubMed ID: 27704873)
21. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
[TBL] [Abstract][Full Text] [Related]
22. Aldose reductase regulates miR-200a-3p/141-3p to coordinate Keap1-Nrf2, Tgfβ1/2, and Zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice.
Wei J; Zhang Y; Luo Y; Wang Z; Bi S; Song D; Dai Y; Wang T; Qiu L; Wen L; Yuan L; Yang JY
Free Radic Biol Med; 2014 Feb; 67():91-102. PubMed ID: 24161443
[TBL] [Abstract][Full Text] [Related]
23. Lumbrokinase attenuates diabetic nephropathy through regulating extracellular matrix degradation in Streptozotocin-induced diabetic rats.
Sun H; Ge N; Shao M; Cheng X; Li Y; Li S; Shen J
Diabetes Res Clin Pract; 2013 Apr; 100(1):85-95. PubMed ID: 23384615
[TBL] [Abstract][Full Text] [Related]
24. The aqueous extract of Lycopus lucidus Turcz ameliorates streptozotocin-induced diabetic renal damage via inhibiting TGF-β1 signaling pathway.
Yao Y; Yang J; Wang D; Zhou F; Cai X; Lu W; Hu C; Gu Z; Qian S; Guan X; Cao P
Phytomedicine; 2013 Oct; 20(13):1160-7. PubMed ID: 23827664
[TBL] [Abstract][Full Text] [Related]
25. Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Xu LP; Zhu ZY; Li JY; Zhou SN; Cui FQ; Zeng XJ; Geng JG; Yang JK
Am J Physiol Renal Physiol; 2014 Mar; 306(5):F486-95. PubMed ID: 24370587
[TBL] [Abstract][Full Text] [Related]
26. Total flavones of Abelmoschus manihot improve diabetic nephropathy by inhibiting the iRhom2/TACE signalling pathway activity in rats.
Liu S; Ye L; Tao J; Ge C; Huang L; Yu J
Pharm Biol; 2017 Dec; 56(1):1-11. PubMed ID: 29221422
[TBL] [Abstract][Full Text] [Related]
27. Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice.
Fujii M; Inoguchi T; Maeda Y; Sasaki S; Sawada F; Saito R; Kobayashi K; Sumimoto H; Takayanagi R
Kidney Int; 2007 Aug; 72(4):473-80. PubMed ID: 17568784
[TBL] [Abstract][Full Text] [Related]
28. Fluorofenidone attenuates diabetic nephropathy and kidney fibrosis in db/db mice.
Wang LH; Liu JS; Ning WB; Yuan QJ; Zhang FF; Peng ZZ; Lu MM; Luo RN; Fu X; Hu GY; Wang ZH; Tao LJ
Pharmacology; 2011; 88(1-2):88-99. PubMed ID: 21847000
[TBL] [Abstract][Full Text] [Related]
29. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
Lai PB; Zhang L; Yang LY
Ren Fail; 2012; 34(1):83-7. PubMed ID: 22011322
[TBL] [Abstract][Full Text] [Related]
30. Effect of catalpol on diabetic nephropathy in rats.
Dong Z; Chen CX
Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
[TBL] [Abstract][Full Text] [Related]
31. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
[TBL] [Abstract][Full Text] [Related]
32. [Effect of tongshenluo capsule on the components of extracellular matrix and their metabolism in kidney of rats with diabetic nephropathy].
Wu YL; Wei C; Wang HT
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Apr; 27(4):326-30. PubMed ID: 17526172
[TBL] [Abstract][Full Text] [Related]
33. Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes.
Lin Y; Sun Z
J Endocrinol; 2011 May; 209(2):185-91. PubMed ID: 21307121
[TBL] [Abstract][Full Text] [Related]
34. miRNA-1 regulates endothelin-1 in diabetes.
Feng B; Cao Y; Chen S; Ruiz M; Chakrabarti S
Life Sci; 2014 Mar; 98(1):18-23. PubMed ID: 24394957
[TBL] [Abstract][Full Text] [Related]
35. Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats.
Qi MY; Kai-Chen ; Liu HR; Su YH; Yu SQ
J Ethnopharmacol; 2011 Dec; 138(3):731-6. PubMed ID: 22027446
[TBL] [Abstract][Full Text] [Related]
36. Protective effects of serum containing Ginkgo biloba extract on glomerulosclerosis in rat mesangial cells.
Tang D; Zhang Z; Gao Y; Wei Y; Han L
J Ethnopharmacol; 2009 Jul; 124(1):26-33. PubMed ID: 19375492
[TBL] [Abstract][Full Text] [Related]
37. Significance of MMP-2 and TIMP-2 mRNA expressions on glomerular cells in the development of glomerulosclerosis.
Zhang ZG; Liu XG; Chen GP; Zhang XR; Guo MY
Chin Med Sci J; 2004 Jun; 19(2):84-8. PubMed ID: 15250240
[TBL] [Abstract][Full Text] [Related]
38. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
[TBL] [Abstract][Full Text] [Related]
39. SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice.
Sugaru E; Nakagawa T; Ono-Kishino M; Nagamine J; Tokunaga T; Kitoh M; Hume WE; Nagata R; Taiji M
Am J Physiol Renal Physiol; 2006 Apr; 290(4):F813-20. PubMed ID: 16278277
[TBL] [Abstract][Full Text] [Related]
40. Resveratrol attenuates early diabetic nephropathy by down-regulating glutathione s-transferases Mu in diabetic rats.
Jiang B; Guo L; Li BY; Zhen JH; Song J; Peng T; Yang XD; Hu Z; Gao HQ
J Med Food; 2013 Jun; 16(6):481-6. PubMed ID: 23767859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]